Nexpoint Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8,236
Closed -$409K 77
2023
Q3
$409K Hold
8,236
0.06% 54
2023
Q2
$490K Buy
8,236
+3,236
+65% +$184K 0.07% 58
2023
Q1
$283K Buy
+5,000
New +$321K 0.03% 71
2022
Q1
Sell
-19,150
Closed -$1.38M 188
2021
Q4
$1.38M Buy
+19,150
New +$1.39M 0.19% 80

Other funds holding GMED

Nexpoint Asset Management's GMED Position: Q4 2023 in Review

Nexpoint Asset Management sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 8,236 shares — an estimated $409K sold.

Nexpoint Asset Management first reported a position in GMED in Q4 2021 and held it in 4 quarters. The position peaked at $1.38M in Q4 2021. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

  • Nexpoint Asset Management reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
  • Nexpoint Asset Management sold 8,236 Globus Medical shares in Q4 2023, an estimated $409K.
  • Nexpoint Asset Management first reported a position in Globus Medical in Q4 2021 and held it in 4 quarters.
  • Nexpoint Asset Management's Globus Medical position peaked at $1.38M in Q4 2021.
  • 408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Nexpoint Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.